| Crizanlizumab for the prevention of pain crises in sickle cell disease KI Ataga, A Kutlar, J Kanter, D Liles, R Cancado, J Friedrisch, TH Guthrie, ... New England Journal of Medicine 376 (5), 429-439, 2017 | 853 | 2017 |
| A phase 3 randomized trial of voxelotor in sickle cell disease E Vichinsky, CC Hoppe, KI Ataga, RE Ware, V Nduba, A El-Beshlawy, ... New England Journal of Medicine 381 (6), 509-519, 2019 | 575 | 2019 |
| A Phase 3 Trial of l-Glutamine in Sickle Cell Disease Y Niihara, ST Miller, J Kanter, S Lanzkron, WR Smith, LL Hsu, ... New England Journal of Medicine 379 (3), 226-235, 2018 | 552 | 2018 |
| Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia VL Patel, M Mahévas, SY Lee, R Stasi, S Cunningham-Rundles, ... Blood, The Journal of the American Society of Hematology 119 (25), 5989-5995, 2012 | 438 | 2012 |
| Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab RA Marsh, CE Allen, KL McClain, JL Weinstein, J Kanter, J Skiles, ND Lee, ... Pediatric blood & cancer 60 (1), 101-109, 2013 | 362 | 2013 |
| Biologic and clinical efficacy of LentiGlobin for sickle cell disease J Kanter, MC Walters, L Krishnamurti, MY Mapara, JL Kwiatkowski, ... New England Journal of Medicine 386 (7), 617-628, 2022 | 211 | 2022 |
| Management of sickle cell disease from childhood through adulthood J Kanter, R Kruse-Jarres Blood reviews 27 (6), 279-287, 2013 | 209 | 2013 |
| Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study M Eapen, R Brazauskas, MC Walters, F Bernaudin, K Bo-Subait, ... The Lancet Haematology 6 (11), e585-e596, 2019 | 163 | 2019 |
| A multinational trial of prasugrel for sickle cell vaso-occlusive events MM Heeney, CC Hoppe, MR Abboud, B Inusa, J Kanter, B Ogutu, ... New England Journal of Medicine 374 (7), 625-635, 2016 | 147 | 2016 |
| Density-based separation in multiphase systems provides a simple method to identify sickle cell disease AA Kumar, MR Patton, JW Hennek, SYR Lee, G D’Alesio-Spina, X Yang, ... Proceedings of the National Academy of Sciences 111 (41), 14864-14869, 2014 | 147 | 2014 |
| Validation of a novel point of care testing device for sickle cell disease J Kanter, MJ Telen, C Hoppe, CL Roberts, JS Kim, X Yang BMC medicine 13, 1-8, 2015 | 127 | 2015 |
| Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: a SUSTAIN study analysis A Kutlar, J Kanter, DK Liles, OA Alvarez, RD Cançado, JR Friedrisch, ... American journal of hematology 94 (1), 55-61, 2019 | 123 | 2019 |
| Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease MM Hsieh, M Bonner, FJ Pierciey Jr, N Uchida, J Rottman, L Demopoulos, ... Blood Advances 4 (9), 2058-2063, 2020 | 114 | 2020 |
| A simple, rapid, low-cost diagnostic test for sickle cell disease X Yang, J Kanter, NZ Piety, MS Benton, SM Vignes, SS Shevkoplyas Lab on a Chip 13 (8), 1464-1467, 2013 | 113 | 2013 |
| Simple paper-based test for measuring blood hemoglobin concentration in resource-limited settings X Yang, NZ Piety, SM Vignes, MS Benton, J Kanter, SS Shevkoplyas Clinical chemistry 59 (10), 1506-1513, 2013 | 110 | 2013 |
| Acute myeloid leukemia case after gene therapy for sickle cell disease S Goyal, J Tisdale, M Schmidt, J Kanter, J Jaroscak, D Whitney, H Bitter, ... New England Journal of Medicine 386 (2), 138-147, 2022 | 106 | 2022 |
| Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects J Kanter, WR Smith, PC Desai, M Treadwell, B Andemariam, J Little, ... Blood Advances 4 (16), 3804-3813, 2020 | 76 | 2020 |
| Addressing sickle cell disease: a strategic plan and blueprint for action RM Martinez, HA Osei-Anto, M McCormick National Academies Press, 2020 | 68 | 2020 |
| Interim results from a phase 1/2 clinical study of lentiglobin gene therapy for severe sickle cell disease J Kanter, MC Walters, MM Hsieh, L Krishnamurti, J Kwiatkowski, ... Blood 128 (22), 1176, 2016 | 65 | 2016 |
| American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation J Kanter, RI Liem, F Bernaudin, J Bolaños-Meade, CD Fitzhugh, ... Blood advances 5 (18), 3668-3689, 2021 | 63 | 2021 |
Victor R. GordeukUniversity of Illinois at Chicago在 uic.edu 的电子邮件经过验证
